SCHEMBL20047526

SCHEMBL20047526

CCCC(C)(CCC)c1cccc2nc(C3CC3)c(C(C)(C)C)nc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20043224 0.85 LCK (0.33) —
SCHEMBL20043221 0.81 CA2 (0.32) —
SCHEMBL23502534 0.81 — —
SCHEMBL23502523 0.80 — —
SCHEMBL23502461 0.75 — —
SCHEMBL23502449 0.73 NR1H2 (0.33) —
SCHEMBL20047453 0.72 KDM4E (0.32) —
SCHEMBL20047605 0.72 CA2 (0.30) —
SCHEMBL23502470 0.68 CNR2 (0.40) —
SCHEMBL20047455 0.68 KCNH2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450306-B2 Isoxazole analogs as FXR agonists and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2019-10-22 — — US disclosed
US-20180099957-A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF ENANTA PHARMACEUTICALS, INC. 2018-04-12 — — US disclosed
Send feedback